TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
YARW

Yarrow Bioscience Inc

Healthcare · Biotechnology

24.00$ -6.0% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

Yarrow Bioscience Inc (YARW) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -33 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Cash Flow YARW
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-4.2 -2.3 -28 -53 -65 -137 -56 -29 -25 -34 -33
– 0.0 0.0 0.0 0.7 0.3 0.1 0.1 – 0.0 0.0
0.1 0.6 1.5 3.6 6.7 18 8.1 4.3 3.3 3.3 2.3
0.4 11 -0.7 -4.2 1.9 -40 4.8 2.3 0.1 5.0 -8.2
0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0
– -37 -15 -34 41 89 1.0 16 -57 23 37
– – – – – – – – – -0.1 –
48 – 49 126 5.0 62 40 1.7 82 -0.1 -0.1
44 -40 6.2 39 -19 14 -16 -12 -0.3 -11 4.1
-4.2 -2.3 -28 -53 -65 -137 -56 -29 -25 -34 -33

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?